SG10201601086WA - Cardiovascular therapeutics - Google Patents

Cardiovascular therapeutics

Info

Publication number
SG10201601086WA
SG10201601086WA SG10201601086WA SG10201601086WA SG10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA SG 10201601086W A SG10201601086W A SG 10201601086WA
Authority
SG
Singapore
Prior art keywords
cardiovascular therapeutics
therapeutics
cardiovascular
Prior art date
Application number
SG10201601086WA
Inventor
Christopher Joseph Pemberton
Arthur Mark Richards
Christopher John Charles
Maithri Siriwardena
Original Assignee
Otago Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otago Innovation Ltd filed Critical Otago Innovation Ltd
Publication of SG10201601086WA publication Critical patent/SG10201601086WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG10201601086WA 2011-08-18 2012-08-17 Cardiovascular therapeutics SG10201601086WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161525140P 2011-08-18 2011-08-18

Publications (1)

Publication Number Publication Date
SG10201601086WA true SG10201601086WA (en) 2016-03-30

Family

ID=47715527

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201400067TA SG11201400067TA (en) 2011-08-18 2012-08-17 Cardiovascular therapeutics
SG10201601086WA SG10201601086WA (en) 2011-08-18 2012-08-17 Cardiovascular therapeutics

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201400067TA SG11201400067TA (en) 2011-08-18 2012-08-17 Cardiovascular therapeutics

Country Status (8)

Country Link
US (2) US9783574B2 (en)
EP (1) EP2744506B1 (en)
JP (1) JP6222779B2 (en)
CN (1) CN103889438B (en)
AU (1) AU2012296266B2 (en)
CA (1) CA2845617A1 (en)
SG (2) SG11201400067TA (en)
WO (1) WO2013024362A2 (en)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155590A (en) 1962-08-02 1964-11-03 Ncr Co Encapsulation process and its product
US3488418A (en) 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
US3391416A (en) 1966-07-14 1968-07-09 Wollard Aircraft Service Equip Conveyance loader system
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
JP4181232B2 (en) 1997-07-18 2008-11-12 帝國製薬株式会社 Diclofenac sodium-containing oily external patch preparation
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
US6410041B1 (en) 1998-04-28 2002-06-25 Trustees Of Tufts College Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine
AU760735B2 (en) 1998-09-28 2003-05-22 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
US20050171021A1 (en) * 1998-11-12 2005-08-04 Cormier Michel J. Buffered drug formulations for transdermal
US6309380B1 (en) 1999-01-27 2001-10-30 Marian L. Larson Drug delivery via conformal film
GB9917165D0 (en) * 1999-07-22 1999-09-22 Knoll Ag Polypeptides polynuclcotides and uses thereof
US6273831B1 (en) * 1999-09-03 2001-08-14 Callaway Golf Company Golf club head with a polymer insert
WO2005052593A1 (en) * 2003-10-29 2005-06-09 The University Of Leicester Detection
AU2005207886A1 (en) * 2004-01-27 2005-08-11 Compugen Usa, Inc. Novel brain natriuretic peptide variants and methods of use thereof
AU2007293777B2 (en) * 2006-09-07 2014-03-20 Otago Innovation Limited Biomarkers

Also Published As

Publication number Publication date
SG11201400067TA (en) 2014-04-28
AU2012296266A1 (en) 2014-03-13
US20130072431A1 (en) 2013-03-21
EP2744506B1 (en) 2019-10-09
US20180148475A1 (en) 2018-05-31
CA2845617A1 (en) 2013-02-21
US9783574B2 (en) 2017-10-10
NZ621790A (en) 2017-09-29
CN103889438A (en) 2014-06-25
WO2013024362A2 (en) 2013-02-21
JP6222779B2 (en) 2017-11-01
WO2013024362A3 (en) 2013-07-25
JP2014524435A (en) 2014-09-22
AU2012296266B2 (en) 2017-08-31
CN103889438B (en) 2016-08-24
EP2744506A2 (en) 2014-06-25
EP2744506A4 (en) 2015-06-03

Similar Documents

Publication Publication Date Title
HK1202051A1 (en) Erythrocyte-binding therapeutics
HK1256421A1 (en) Erythrocyte-binding therapeutics
GB2507211B (en) Trampoline
ZA201309278B (en) Trampolines
GB201204966D0 (en) Djml
EP2729605A4 (en) Rna-yy1 interactions
EP2723631A4 (en) Quadfolier
PL2525128T3 (en) Transition piece
GB2535351B (en) Trampoline
IL228668A0 (en) Micro-thermocouple
GB201119167D0 (en) Novel bachteriophages
IL227377A0 (en) Combinations
SG10201601086WA (en) Cardiovascular therapeutics
GB201108220D0 (en) Bungee spongee
GB201113923D0 (en) Novel combinations
GB201108290D0 (en) Solid supports
GB201116426D0 (en) Novel saccharide based therapeutics
GB201118263D0 (en) Corcost-CH001
GB201116956D0 (en) Kinibra
GB201116532D0 (en) Wheel-spray
GB201115246D0 (en) Grabi-safe
GB201115238D0 (en) Pit-stop easy
GB201113987D0 (en) Discretion
AU338110S (en) Barstool
GB201112214D0 (en) Wheelaway